Magnetic resonance spectroscopy and imaging can differentiate between engineered bone and engineered cartilage

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Medical Imaging

Background:

• Osteochondral defects require tissue engineering solutions.
• Non-invasive monitoring of both cartilage and bone development is crucial.
• Nuclear magnetic resonance (NMR) spectroscopy and magnetic resonance imaging (MRI) are established non-invasive assessment tools.

Purpose of the Study:

• To evaluate differences in MR properties between tissue-engineered bone and cartilage.
• To assess early-stage tissue growth in constructs derived from the same cell-scaffold combination.
• To determine the efficacy of NMR and MRI in differentiating developing osteochondral tissues.

Main Methods:

• Human marrow stromal cells (HMSCs) seeded in collagen/chitosan scaffolds.
• Chondrogenic or osteogenic differentiation induced by specific growth factors.
• Proton and sodium NMR, along with water proton T1, T2, and diffusion MRI experiments performed at 9.4 T and 11.7 T.

Main Results:

• NMR and MRI clearly distinguished between developing bone and cartilage tissues.
• MR properties showed significant differences between the two engineered tissues.
• The control scaffold also showed distinct MR characteristics.

Conclusions:

• NMR spectroscopy and MRI are effective non-invasive tools for monitoring osteochondral tissue regeneration.
• These techniques allow for clear differentiation of developing cartilage and bone.
• The findings support the use of MRS and MRI in assessing the progress of tissue-engineered osteochondral constructs.